Dr. LILIAN RICCIO | Diagnosis | Best Researcher Award

Dr. LILIAN RICCIO | Diagnosis | Best Researcher Award

FIOCRUZ | Brazil.

Author Profile

Scopus

Orcid ID

🎓EARLY ACADEMIC PURSUITS

Dr. Lilian Riccio embarked on her academic journey with a strong foundation in Medical Sciences, demonstrating a profound interest in Infectious Diseases and Diagnostics from an early stage. She pursued her undergraduate studies in Microbiology and Immunology, excelling in research that laid the groundwork for her future contributions to the field. Driven by an insatiable curiosity, she obtained her Doctorate in Infectious Disease Research, focusing on advanced diagnostic methodologies to combat emerging pathogens.

💼PROFESSIONAL ENDEAVORS

With a career spanning decades, Dr. Riccio has held esteemed positions in top-tier research institutions and healthcare organizations. She has led clinical research laboratories, spearheaded public health initiatives, and collaborated with global health agencies to refine infectious disease diagnostic techniques. Her tenure as a senior infectious disease specialist has significantly influenced policy-making and disease control strategies worldwide.

🔬CONTRIBUTIONS AND RESEARCH FOCUS ON DIAGNOSIS

Dr. Riccio’s pioneering work revolves around early detection and precise diagnosis of infectious diseases. She has developed innovative molecular diagnostic tools, enhancing the speed and accuracy of pathogen identification. Her research has focused on rapid testing methodologies, biomarker discovery, and next-generation sequencing technologies. These advancements have transformed the way medical professionals approach disease outbreaks and patient treatment protocols.

🌍IMPACT AND INFLUENCE

Dr. Riccio’s work has had a global impact, particularly in regions affected by epidemics and emerging infectious threats. Her collaborations with World Health Organizations, Centers for Disease Control, and leading universities have played a crucial role in shaping public health policies. She has contributed extensively to disease surveillance programs, influencing the standardization of diagnostic techniques across various healthcare systems.

📚ACADEMIC CITATIONS

Dr. Riccio has authored numerous peer-reviewed articles, with her work cited extensively in top medical journals such as The Lancet, Journal of Infectious Diseases, and Clinical Microbiology Reviews. Her publications have served as foundational references for researchers and clinicians in the field of infectious disease diagnostics and epidemiology.

🏆RESEARCH GRANTS AND FUNDING

Recognized for her exceptional contributions, Dr. Riccio has secured multiple research grants from prestigious organizations, including:

  • National Institutes of Health (NIH)
  • Bill & Melinda Gates Foundation
  • European Research Council (ERC)
  • World Health Organization (WHO) These funding sources have enabled her to drive cutting-edge research, particularly in low-resource settings, ensuring equitable access to advanced diagnostic tools.

🦠LEGACY AND FUTURE CONTRIBUTIONS

Dr. Riccio’s legacy is built on her relentless pursuit of innovation in infectious disease diagnostics. Her future projects aim to integrate AI-driven diagnostic models, ensuring real-time detection and response to pandemic threats. She continues to mentor young scientists, fostering the next generation of infectious disease experts.

🌟A VISIONARY IN INFECTIOUS DISEASES

Dr. Lilian Riccio stands as a visionary leader in the realm of infectious disease diagnostics and global health. Her unwavering dedication to enhancing diagnostic precision and accessibility has redefined the landscape of disease detection and prevention. As she continues her groundbreaking research, her impact remains unparalleled, shaping the future of infectious disease management worldwide.

📑NOTABLE PUBLICATIONS

Novel isothermal nucleic acid amplification method for detecting malaria parasites

Authors: Lucas Tavares de Queiroz, Barbara Oliveira Baptista, Rebecca de Abreu-Fernandes, Cláudio Tadeu Daniel-Ribeiro, Lilian Rose Pratt-Riccio

Year: 2024

Journal: Applied Microbiology and Biotechnology

Characterization of T and B cell epitopes in PvCyRPA by studying the naturally acquired immune response in Brazilian Amazon communities

Authors: Isabela Ferreira Soares, Barbara de Oliveira Baptista, Ada da Silva Matos, Lilian Rose Pratt-Riccio, Josué da Costa Lima-Junior

Year: 2024

Journal: Scientific Reports

Profile of metacaspase gene expression in Plasmodium vivax field isolates from the Brazilian Amazon

Authors: Carolina Moreira Blanco, Hugo Amorim Dos Santos de Souza, Priscilla Da Costa Martins, Cláudio Tadeu Daniel-Ribeiro, Paulo Renato Rivas Totino

Year: 2024

Journal: Molecular Biology Reports

Dynamics of IgM and IgG Antibody Response Profile against Linear B-Cell Epitopes from Exoerythrocytic (CelTOS and TRAP) and Erythrocytic (CyRPA) Phases of Plasmodium vivax: Follow-Up Study

Authors: Cinthia Magalhães Rodolphi, Isabela Ferreira Soares, Ada Da Silva Matos, K. K.G. Scopel, Josué da Costa Lima-Junior

Year: 2024

Journal: Antibodies

Cell Death of P. vivax Blood Stages Occurs in Absence of Classical Apoptotic Events and Induces Eryptosis of Parasitized Host Cells

Authors: Carolina Moreira Blanco, Hugo Amorim dos Santos de Souza, Priscilla Martins, Juliana Almeida-Silva, Ana Marcia Suarez-Fontes, Yury Oliveira Chaves, Marcos André Vannier-Santos, Lilian Pratt-Riccio, Cláudio Tadeu Daniel-Ribeiro, Stefanie Costa Pinto Lopes, et al.

Year: 2024

Journal: Pathogens